A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Clinical trial NCT02671435 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02671435
Sponsor: MedImmune LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2016-02-22
Primary completion: 2021-10-26
Enrollment: 383

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.